Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 8, 2003, Pages 943-949

  Noto, Hiroshi ^a   Terao, Toshihiko ^a   Ryou, Shigeo ^b   Hirose, Yasuyuki ^c   Yoshida, Takami ^d   Ookubo, Hideo ^e   Mito, Hidetoshi ^f   Yoshizawa, Hiroshi ^a,g  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Numazu City Hospital   (Japan)

^c Shimada City Hospital   (Japan)

^d Shizuoka Kodomo Hospital   (Japan)

^e Shizuoka Prefectural General Hospital   (Japan)

^f Assoc of Prev Medicine in Shizuoka   (Japan)

^g HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Hepatitis B e antigen; Hepatitis B surface antigen; Hepatitis B vaccines; Hepatitis B virus; Immunoglobulins; Perinatal care

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; IMMUNIZATION; IMMUNOPROPHYLAXIS; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PASSIVE IMMUNIZATION; PERINATAL CARE; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0041853049     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03092.x     Document Type: Article

References (20)

1. Lee WM. Hepatitis B virus infection. N. Engl. J. Med. 1997; 337: 1733-45.
2. World Health Organization. Geographic pattern of hepatitis B prevalence, 1997. Available from: URL: http://www.who.int/vaccines-surveillance/graphics/htlms/hepbprev.htm.
3. Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 1996; 38 (Suppl.): S39-42.
4. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N. Engl. J. Med. 1976; 294: 746-9.
5. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: Correlation with vertical transmission of hepatitis B virus in Taiwan. J. Med. Virol. 1979; 3: 237-41.
6. Otake K, Nishioka K. Nucleic acid amplification testing of hepatitis B virus. Lancet 2000; 355: 1460.
7. Tada H, Yanagida M, Mishina J et al. Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics 1982; 70: 613-19.
8. Stevens CE, Taylor PE, Tong MJ et al. Yeast-recombinant hepatitis B vaccine: Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987; 257: 2612-16.
9. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J. Infect. Dis. 1994; 170: 1418-23.
10. Shiraki K. Perinatal transmission of hepatitis B virus and its prevention. J. Gastroenterol. Hepatol. 2000 (Suppl.); 15: S11-15.
11. Shiraki K, Yoshihara N, Sakurai M, Eto T, Kawana T. Acute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen. J. Pediatr. 1980; 97: 768-70.
12. Sinatra FR, Shah P, Weissman JY, Thomas DW, Merritt RJ, Tong MJ. Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis Be-positive carrier mothers. Pediatrics 1982; 70: 557-9.
13. Terazawa S, Kojima M, Yamanaka T et al. Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr. Res. 1991; 29: 5-9.
14. Crawford NG, Pruss AM. Preventing neonatal hepatitis B infection during the perinatal period. J. Obstet. Gynecol. Neonatal Nurs. 1993; 22: 491-7.
15. Marshall E. A shadow falls on hepatitis B vaccination effort. Science 1998; 281: 630-1.
16. Lin HH, Chang MH, Chen DS et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: Analysis of prophylaxis failure. Vaccine 1991; 9: 457-60.
17. Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 1997; 336: 1855-9.
18. Prevention of perinatal hepatitis B through enhanced case management: Connecticut, 1994-95, and the United States, 1994. MMWR Morb. Mortal. Wkly. Rep. 1996; 45: 584-7.
19. Kohn MA, Farley TA, Scott C. The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: Lessons from the Louisiana Perinatal Hepatitis B Immunization Program. Pediatr. Infect. Dis. J. 1996; 15: 535-40.
20. Program to prevent perinatal hepatitis B virus transmission in a health- maintenance organization: Northern California, 1990-95. MMWR Morb. Mortal. Wkly. Rep. 1997; 46: 378-80.